Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 12:36:272.
doi: 10.11604/pamj.2020.36.272.17827. eCollection 2020.

Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria

Affiliations

Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria

Kehinde Sharafadeen Okunade et al. Pan Afr Med J. .

Abstract

Introduction: epithelial ovarian cancer (EOC) is the most lethal gynaecological cancer with a recurrence rate as high as 85% after an initial treatment. However, there are currently no reliable means of predicting the risk of recurrence after first-line treatment. This study investigated the risk factors that predict early recurrence of EOC after primary treatment among women in Lagos, Nigeria.

Methods: this was a retrospective cohort study involving the review of all histologically confirmed EOC patients managed at the Lagos University Teaching Hospital, Lagos, Nigeria over a 7-year period from January 2010 to December 2016. A study proforma was used to retrieve relevant information and descriptive statistics were computed for all data. The associations between variables were tested and multivariate analysis was done to adjust for all the possible characteristics that predict early EOC recurrence.

Results: the rate of recurrence of EOC was 76.4%. Suboptimal debulking surgery is the only independent predictor of early tumour recurrence.

Conclusion: women should be adequately counselled and encouraged to report their symptoms early to ensure optimal primary treatment. Strategic efforts should also be made to further improve subspecialty training programs and skills development in gynaecological oncology in Nigeria and sub-Saharan Africa.

Keywords: Cytoreduction; FIGO stage; Lagos; epithelial ovarian cancer; recurrence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Similar articles

Cited by

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
    1. Iyoke CA, Ugwu GO. Burden of gynaecological cancers in developing countries. World Obstet Gynaecol. 2013;2(1):1–7.
    1. Nkyekyer K. Pattern of gynaecological cancers in Ghana. East Afr Med J. 2000;77(10):534–8. - PubMed
    1. Ugwu EO, Iferikigwe ES, Okeke TC, Ugwu AO, Okezie OA, Agu PU. Pattern of gynaecological cancers in University of Nigeria Teaching Hospital, Enugu, South Eastern Nigeria. Niger J Med. 2011;20(2):266–9. - PubMed
    1. Buhari MO, Ojo BA, Ijaiya MA, Aboyeji PA. Ovarian cancers in Ilorin, Nigeria-a review of over 80 cases. Nig Q J Hosp Med. 2005;15(3):127–30.